Bactericidal Activity Changes in Saliva During Post-Covid
In the post-covid period, changes occur in the oral cavity, which may be caused by the action of a new coronavirus infection. Studies show that the virus can negatively affect the cells of the oral mucosa, which in turn leads to a decrease in local immunity. The lack of protective factors makes the body more vulnerable to the virus and can lead to complications. The aim of the study is to analyze changes in the parameters of immunoglobulins in oral fluid of patients before and after a new coronavirus infection. The literature analysis was carried using the following scientometric databases: PubMed, Scopus, Google Academy, Rospatent, RSCI. This article describes changes in the composition of saliva and a decrease in its amount in the post-covoid period and provides links to 39 scientific publications. Literature analysis showed that, in the post-covid period, changes in the parameters of secretory IgA, salivation rate of saliva and lysozyme activity occur in saliva and oral fluid.
Vinnik A.V., Simonova E.A., Postnikov M.A., Vinnik S.V., Lyamin A.V. 2024. Bactericidal Activity Changes in Saliva During Post-Covid. Challenges in Modern Medicine, 47(2): 199–209 (in Russian). DOI: 10.52575/2687-0940-2024-47-2-199-209
While nobody left any comments to this publication.
You can be first.
Afanas'ev V.V. 2012. Sljunnye zhelezy. Bolezni i travmy: rukovodstvo dlja vrachej [Salivary Glands. Diseases and Injuries: A Guide for Doctors]. GJeOTAR-Media: 296.
Bekzhanova O.E., Kajumova V.R., Shukurova U.A. 2022. Pokazateli smeshannoj sljuny u pacientov v postkovidnom periode [Indicators of Mixed Saliva in Patients in the Postcovid Period]. Medicinskie novosti, 6(333): 72–75.
Vinnik A.V., Postnikov M.A., Ljamin A.V., Tkach T.M., Vinnik S.V. 2021. Povyshenie jeffektivnosti diagnostiki zabolevanij tkanej parodonta s primeneniem sovremennogo metoda issledovanija [Improving the Effectiveness of the Diagnosis of Periodontal Tissue Diseases Using a Modern Research Method]. Aspirantskij vestnik Povolzh'ja: 49–53.
Vinnik A.V. 2022. Metody zabora soderzhimogo zubodesnevogo zhelobka [Methods of Collecting the Contents of the Dentoalveolar Groove]. Saratovskij nauchno-medicinskij zhurnal, 3: 315–319.
Viha G.V. 2013. Sekretornyj immunoglobulin A – marker adaptacii organizma cheloveka k vneshnim vozdejstvijam [Secretory Immunoglobulin A is a Marker of Adaptation of the Human Body to External Influences]. Laboratornaja diagnostika, 3: 15–17.
Vorob'eva P.A. 2021. Rekomendacii po vedeniju bol'nyh s koronavirusnoj infekciej COVID-19 v ostroj faze i pri postkovidnom sindrome v ambulatornyh uslovijah [Recommendations for the Management of Patients with COVID-19 Coronavirus Infection in the Acute Phase and with Postcovid Syndrome on an Outpatient Basis]. Problemy standartizacii v zdravoohranenii, 7–8: 3–96. doi: 10.26347/1607- 2502202107-08003-096
Zaljalieva M.V., Rashidova F.M., Nuruzova Z.A., Abdukadyrova M.U., Mirahmedova N.N. 2022. Pokazateli vrozhdjonnogo (lizocim) i adaptivnogo (SIGA) immuniteta v sljune bol'nyh COVID-19 [Indicators of Innate (Lysozyme) and Adaptive (Whitefish) Immunity in the Saliva of Patients with COVID-19]. Teoreticheskaja i klinicheskaja medicina, 2: 90–93.
Iordanishvili A.K., Malyshev M.E., Shvecov M.M. 2022. Korrekcija immunnyh disfunkcij v polosti rta u ljudej, perenesshih novuju koronavirusnuju infekciju covid-19 [Correction of Immune Dysfunctions in the Oral Cavity in People Who Have Suffered a New Coronavirus Infection COVID-19]. Institut stomatologii, 3(96): 54–57.
Kaljuzhin O.V. 2018. Antibakterial'nye, protivogribkovye, protivovirusnye i immunomodulirujushhie jeffekty lizocima: ot mehanizmov k farmakologicheskomu primeneniju [Antibacterial, Antifungal, Antiviral and Immunomodulatory Effects of Lysozyme: From Mechanisms to Pharmacological Use]. Pediatrija, 1: 6–12.
Kaljuzhin O.V. 2018. Antibakterial'nye, protivogribkovye, protivovirusnye i immunomodulirujushhie jeffekty lizocima: ot mehanizmov k farmakologicheskomu primeneniju [Antibacterial, Antifungal, Antiviral and Immunomodulatory Effects of Lysozyme: From Mechanisms to Pharmacological Use]. Effektivnaya farmakoterapiya, 14: 6–13.
Kartashova A.K., Pankratov T.A. 2021. Vlijanie gormonov cheloveka na aktivnost' lizocima v laboratornyh uslovijah [The Effect of Human Hormones on Lysozyme Activity in the Laboratory]. Perspektivnye napravlenija fiziko-himicheskoj biologii i biotehnologii: 16.
Keshhenko A. O. 2021. Osobennosti razvitija rynka medicinskih uslug v uslovijah pandemii COVID-19 v Rostovskoj oblasti [Features of the Development of the Medical Services Market in the Context of the COVID-19 Pandemic in the Rostov Region]. In: A.O. Keshhenko, Aktual'nye problemy razvitija jekonomiki i upravlenija v sovremennyh uslovijah [Current Problems of Economic Development and Management in Modern Conditions]. Ed. T.S. Sajapinoj. Moskva, Sbornik materialov IV Mezhdunarodnoj nauchno-prakticheskoj konferencii: 440–449.
Krjukova N.O., Rakunova E.B., Kostinov M.P., Baranova I.A., Svitich O.A. 2021. Sekretornyj immunoglobulin A respiratornoj sistemy i COVID-19 [Secretory Immunoglobulin A of the Respiratory System and COVID-19]. Pul'monologija, 31(6): 792–798. doi: 10.18093/0869-0189-2021-31-6-792-798.
Kuznecov A.V. 2012. Immunoglobulin A u detej, sovremennye predstavlenija o ego protivovospalitel'nyh i provospalitel'nyh jeffektornyh funkcijah [Immunoglobulin A in Children, Modern Ideas about its Anti-Inflammatory and Pro-Inflammatory Effector Functions]. Fundamental'nye issledovanija, 2: 198–203.
Luchihin L.A. 2003. Racional'nye podhody k lecheniju i profilaktiki respiratornyh infekcij [Rational Approaches to the Treatment and Prevention of Respiratory Infections]. Consilium Medicum, 5(2).
Malyshev M.E., Shvecov M.M., Iordanishvili A.K. 2022. Postkovidnyj sindrom: osobennosti podgotovki k dental'noj implantacii [Postcovoid Syndrome: Features of Preparation for Dental Implantation]. Zdorov'e – osnova chelovecheskogo potenciala: problemy i puti ih reshenija, 17(2): 845–852.
Oksuzjan A.V., Petrova A.R., Perevoshhikova D.K., Stepanova E.S. 2022. Izmenenija sostojanija parodonta posle perenesennyh virusnyh zabolevanij v period pandemii COVID-19 [Changes in the Periodontal Condition after Viral Diseases During the COVID-19 Pandemic]. Modern Science, 3(1): 207–210.
Orehov S.N., Matveev S.V., Karakjan A.Je., Ibragimova Je.Z. 2017. Prichiny narushenija sekrecii sljunnyh zhelez i sposoby lechenija [Changes in the Periodontal Condition after Viral Diseases During the COVID-19 Pandemic]. Nauchnoe obozrenie. Medicinskie nauki, 4: 58–64.
Piljugin A. V. 2007. Sovremennye predstavlenija o strukture i funkcii malen'kih sljunnyh zhelez cheloveka [Modern Ideas about the Structure and Function of Small Human Salivary Glands]. Aktual'nye problemy sovremennoj mediciny: Vestnik ukrainskoj medicinskoj stomatologicheskoj akademii, 7(3): 207–211.
Ruleva A.A., Popova V.V., Ljovina A.V., Krasnov A.A., Petlenko S.V. 2021. Immunologicheskie mehanizmy dejstvija preparata Citovir-3 v osnove profilaktiki ostryh respiratornyh virusnyh infekcij i grippa [Immunological Mechanisms of Action of the Drug Cytovir-3 Are the Basis for the Prevention of Acute Respiratory Viral Infections and Influenza]. Immunologija, 42(2): 148–158.
Satygo E.A., Bakulin I.G., Limina A.P. 2021. Indeks gigieny polosti rta i nekotorye pokazateli rotovoj zhidkosti u pacientov s postkovidnym sindromom pri ispol'zovanii razlichnyh zubnyh past [The Index of Oral Hygiene and Some Indicators of Oral Fluid in Patients with Postcovid Syndrome when Using Various Toothpastes]. Parodontologija, 26(4): 301–307.
Safiullin A.I., Askarova L.I., Mirahmedova N.N., Papina E.S. 2015. Koncentracija immunoglobulinov osnovnyh klassov (A, M, G) v krovi i sljune u VICh-inficirovannyh s oral'nymi porazhenijami [The Concentration of Immunoglobulins of the Main Classes (A, M, G) in the Blood and Saliva of HIV-Infected People with Oral Lesions]. Teoreticheskaja i klinicheskaja medicina, 2: 130–134.
Sulajmonova G.T., Shomuratova R.K., Ahmedova F.N., Safarov B.N. 2021. Harakteristika izmenenij slizistoj obolochki i mikroflory polosti rta pri koronovirusnoj infekcii [Characteristics of Changes in the Mucous Membrane and Microflora of the Oral Cavity in Coronavirus Infection]. In: Science and Education: Problems and Innovations. Ed. Guljaev G. Ju. Penza, Penza: Nauka i Prosveshhenie: 154–158.
Tereshina T.P., Kot M.I. 2020. Vpliv COVID-19 na funkcional'nuju aktivnist' slinih zaloz (poperednє doslidzhennja) [Effect of COVID-19 on the Functional Activity of the Salivary Glands (Preliminary Study)]. Vіsnik stomatologії, 113(4): 35–38.
Halatov V.A, Gulin A.V, Nevzorova E.V. 2015. Immunologicheskie pokazateli sljuny u zhitelej Lipeckoj oblasti [Immunological Parameters of Saliva in Residents of the Lipetsk Region]. Vestnik rossijskih universitetov. Matematika, 20(2): 354–66.
Hasanova A.A., Kostinov M.P., Solov'eva I.L. 2022. Mukozal'nyj immunitet v periode reabilitacii u pacientov posle perenesennoj koronavirusnoj infekcii [Mucosal Immunity in the Rehabilitation Period in Patients after Coronavirus Infection]. Rossijskij immunologicheskij zhurnal, 25(4): 549–554. doi: 10.46235/1028-7221-1190
Hasanova A.A., Kostinov M.P., Solov'eva I.L., Popondopolo I.O. 2022. Vozmozhnosti korrekcii urovnja sekretornogo IGA u lic v postkovidnom periode [The Possibilities of Correcting the Level of Secretory IGA in Individuals in the Postcovid Period]. Problemy medicinskoj mikologii, 24(2): 144.
Chochaeva Z.A., Nazarova A.A., Mahieva M.K., Musaeva K.N. 2022. Osnovnye izmenenija polosti rta u pacientov, perenesshih COVID-19 [The Main Changes in the Oral Cavity in Patients Who Have Undergone COVID-19]. Sovremennaja nauka: aktual'nye problemy teorii i praktiki, 11: 250–253. doi: 10.37882/2223-2966.2022.11.40
Shvecov M.M., Malyshev M.E., Iordanishvili A.K. 2022. Vozmozhnosti otechestvennyh individual'nyh sredstv uhoda za polost'ju rta v ustranenii stomatologicheskih projavlenij posledstvij novoj koronavirusnoj infekcii COVID-19 [The Possibilities of Domestic Individual Oral Care Products in Eliminating Dental Manifestations of the Consequences of the New Coronavirus Infection COVID-19]. Medicinskij alfavit, 2: 25–29. doi: 10.33667/2078-5631-2022-2-25-29
Bompard F., Monnier H., Saab I. 2020. Pulmonary Embolism in Patients with COVID-19 pneumonia. Eur. Respir. J., 56.
Carreras-Presas C.M., Sánchez J.A., López- Sánchez A.F., Jané-Salas E., Pérez M.L. 2020. Oral Vesiculobullous Lesions Associated with SARS-CoV-2 Infection. Oral Dis.
Criel M., Falter M., Jaeken J. 2020. Venous Thromboembolism in SARS-CoV-2 Patients: only a Problem in Ventilated ICU Patients, or is there More To It. Eur. Respir. J., 56.
Danzi G.B., Loffi M., Galeazzi G. Acute Pulmonary Embolism and COVID-19 Pneumonia: a Random Association. Eur. Heart J., 41: 1858.
Azzi L., Maurino V., Baj A. 2020. Diagnostic Salivary Tests for SARS-CoV-2. J. Dent Res. doi: 10.1177/0022034520969670
Han P. Saliva-Friend and Foe in the COVID-19 Outbreak. Diagnostics (Basel), 10(5): 290. doi: 10.3390/diagnostics10050290
Lee-Huang S., Maiorov V., Huang P.L. 2005. Structural and Functional Modeling of Human Lysozyme Reveals a Unique Nonapeptide, HL9, with Anti-HIV Activity. Biochemistry, 44(12): 4648–4655.
The work carried out without external sources of funding.